Can Cemiplimab Become a Life-Changer in Xeroderma Pigmentosum?

• Maria Boziou,
• Dimitrios Dionyssiou,
• Dimitrios Dionyssopoulos,
• Elizabeth Lazaridou,
• Aimilios Lallas,
• Zoe Apalla

Affiliations

Maria Boziou

Second Dermatology Department, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece

Dimitrios Dionyssiou

Department of Plastic Surgery, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece

Dimitrios Dionyssopoulos

Department of Medical Oncology, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece

Elizabeth Lazaridou

Second Dermatology Department, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece

Aimilios Lallas

First Dermatology Department, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece

Zoe Apalla

First Department of Dermatology, Aristotle University Thessaloniki, Greece